Topic: Shingles

gsk sign2

7. GlaxoSmithKline

It was something of a rebuilding year for GlaxoSmithKline in 2017. It was CEO Emma Walmsley's first at the helm, and the company subsequently won three blockbuster approvals for shingles vaccine Shingrix, COPD med Trelegy and HIV drug Juluca.